Irvine, CA, United States of America

Jonathan York Bass, Iii

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Glaxosmithkline LLC. Active years: 2011.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jonathan York Bass, Iii. Retrieved from https://idiyas.com/inventor/jonathan-york-bass-iii

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2011

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Jonathan York Bass, III

Introduction

Jonathan York Bass, III is an accomplished inventor based in Irvine, California. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on farnesoid X receptor agonists. His research and inventions have the potential to impact therapeutic applications significantly.

Latest Patents

Jonathan holds one patent for his invention titled "Farnesoid X receptor agonists." This patent provides novel substituted isoxazole compounds, pharmaceutical compositions, therapeutic uses, and processes for preparing the same. His work in this area showcases his commitment to advancing medical science and improving patient outcomes.

Career Highlights

Jonathan is currently employed at GlaxoSmithKline LLC, a leading global healthcare company. His role at GlaxoSmithKline allows him to collaborate with other talented professionals in the field. His contributions to the company and the pharmaceutical industry are noteworthy.

Collaborations

Some of Jonathan's coworkers include Justin Caravella and David Norman Deaton. Their collaborative efforts contribute to the innovative environment at GlaxoSmithKline, fostering advancements in pharmaceutical research and development.

Conclusion

Jonathan York Bass, III exemplifies the spirit of innovation in the pharmaceutical industry. His work on farnesoid X receptor agonists highlights his dedication to improving healthcare through scientific advancements. His contributions will undoubtedly continue to influence the field for years to come.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…